343.80
-13.20
(-3.70%)
As of 8:00:44 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
1,136,600.00
978,000.00
802,500.00
598,200.00
755,700.00
Investing Cash Flow
582,500.00
-719,600.00
-811,500.00
-486,900.00
-738,500.00
Financing Cash Flow
-1,272,900.00
-11,900.00
75,400.00
44,800.00
-16,900.00
End Cash Position
1,553,900.00
1,207,700.00
961,200.00
894,800.00
738,700.00
Income Tax Paid Supplemental Data
385,900.00
332,500.00
275,700.00
153,300.00
92,800.00
Interest Paid Supplemental Data
47,200.00
56,000.00
29,100.00
16,200.00
20,700.00
Capital Expenditure
-238,500.00
-230,400.00
-138,800.00
-120,800.00
-59,300.00
Issuance of Debt
--
--
800,000.00
--
--
Repayment of Debt
-400,000.00
-100,000.00
-800,000.00
--
-50,000.00
Repurchase of Capital Stock
-1,012,000.00
-13,800.00
-11,400.00
-10,800.00
-3,700.00
Free Cash Flow
898,100.00
747,600.00
663,700.00
477,400.00
696,400.00
12/31/2020 - 2/29/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ANEB Anebulo Pharmaceuticals, Inc.
1.5900
+2.58%
TYRA Tyra Biosciences, Inc.
14.71
+0.41%
PVLA Palvella Therapeutics, Inc.
13.50
+1.43%
FENC Fennec Pharmaceuticals Inc.
6.55
+1.24%
MLYS Mineralys Therapeutics, Inc.
10.27
-0.87%
GBIO Generation Bio Co.
0.8128
-5.44%
KALV KalVista Pharmaceuticals, Inc.
8.77
0.00%
ZURA Zura Bio Limited
1.7600
+1.73%
RZLT Rezolute, Inc.
5.21
+2.96%
VRDN Viridian Therapeutics, Inc.
20.08
+3.35%